| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
134,770,000 |
| Market
Cap: |
24.12(B) |
| Last
Volume: |
808,451 |
Avg
Vol: |
1,130,093 |
| 52
Week Range: |
$146.9 - $182.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 226 |
| Guru Rank Value : 6.9 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
16,014 |
74,539 |
199,512 |
218,029 |
| Total Sell Value |
$2,728,556 |
$12,661,571 |
$32,577,435 |
$34,946,548 |
| Total People Sold |
2 |
6 |
8 |
8 |
| Total Sell Transactions |
3 |
17 |
25 |
33 |
| End Date |
2025-05-22 |
2025-02-18 |
2024-08-20 |
2023-08-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kuppusamy Karthik |
SVP, Clinical Solutions |
• – – |
2025-08-13 |
4 |
D |
$175.91 |
$21,637 |
D/D |
(123) |
8,338 |
|
- |
|
| Plewman Patrick |
SVP for Diagnostic Services |
• – – |
2025-08-06 |
4 |
AS |
$175.00 |
$968,625 |
D/D |
(5,535) |
19,219 |
|
4% |
|
| Plewman Patrick |
SVP for Diagnostic Services |
• – – |
2025-08-06 |
4 |
OE |
$86.63 |
$308,403 |
D/D |
3,560 |
24,745 |
|
- |
|
| Kuppusamy Karthik |
SVP, Clinical Solutions |
• – – |
2025-07-31 |
4 |
AS |
$170.00 |
$375,700 |
D/D |
(2,210) |
8,450 |
|
7% |
|
| Kuppusamy Karthik |
SVP, Clinical Solutions |
• – – |
2025-07-30 |
4 |
AS |
$167.40 |
$1,384,231 |
D/D |
(8,269) |
10,660 |
|
7% |
|
| Kuppusamy Karthik |
SVP, Clinical Solutions |
• – – |
2025-07-30 |
4 |
OE |
$86.63 |
$849,764 |
D/D |
8,269 |
15,884 |
|
- |
|
| Delaney Mark E |
SVP & Chief Commercial Officer |
• – – |
2025-07-21 |
4 |
A |
$167.49 |
$2,847 |
D/D |
17 |
7,515 |
|
- |
|
| Plewman Patrick |
SVP for Diagnostic Services |
• – – |
2025-07-21 |
4 |
A |
$167.49 |
$13,400 |
D/D |
80 |
21,185 |
|
- |
|
| Carter Robert B |
Director |
– • – |
2025-07-21 |
4 |
A |
$167.51 |
$1,173 |
D/D |
7 |
2,692 |
|
- |
|
| Lassiter Wright Iii |
Director |
– • – |
2025-07-21 |
4 |
A |
$167.51 |
$1,173 |
D/D |
7 |
9,044 |
|
- |
|
| Samad Samer Abdul |
Executive Vice President & CFO |
• – – |
2025-07-21 |
4 |
A |
$167.50 |
$12,060 |
D/D |
72 |
25,673 |
|
- |
|
| Gregg Vicky B |
Director |
– • – |
2025-07-21 |
4 |
A |
$167.50 |
$13,232 |
D/D |
79 |
18,217 |
|
- |
|
| Kuppusamy Karthik |
SVP, Clinical Solutions |
• – – |
2025-07-21 |
4 |
A |
$167.50 |
$4,522 |
D/D |
27 |
10,660 |
|
- |
|
| Samad Samer Abdul |
Executive Vice President & CFO |
• – – |
2025-07-16 |
4 |
D |
$169.01 |
$143,659 |
D/D |
(850) |
25,601 |
|
- |
|
| Gregg Vicky B |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
18,138 |
|
- |
|
| Pfeiffer Gary M |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
30,669 |
|
- |
|
| Lassiter Wright Iii |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
9,037 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
29,507 |
|
- |
|
| Morrison Denise M |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
10,742 |
|
- |
|
| Main Timothy L |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
26,297 |
|
- |
|
| Carter Robert B |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
2,685 |
|
- |
|
| Diaz Luis |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
4,054 |
|
- |
|
| Doi Tracey |
Director |
– • – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
6,490 |
|
- |
|
| Delaney Mark E |
SVP & Chief Commercial Officer |
• – – |
2025-05-13 |
4 |
AS |
$175.31 |
$153,221 |
D/D |
(874) |
7,498 |
|
3% |
|
| Delaney Mark E |
SVP & Chief Commercial Officer |
• – – |
2025-05-12 |
4 |
AS |
$175.72 |
$153,579 |
D/D |
(874) |
8,372 |
|
2% |
|
812 Records found
|
|
Page 1 of 33 |
|
|
0.82 (0.46%) 
